Prophylactic Laser Treatment of Drusen Maculopathy

This study is currently recruiting participants.

Verified by University Hospital, Linkoeping, October 1999

Sponsored by:	University Hospital, Linkoeping
Information provided by:	University Hospital, Linkoeping
ClinicalTrials.gov Identifier:	NCT00348543

Purpose

To study the effect of mild laser treatment on the incidence of exudative complications in soft drusen maculopathy. We hypothesise that mild laser treatment causing a proliferation of the retinal pigment epithelium and enhancing the capacity of clearing drusen material from Bruch's membrane.

Condition	Intervention
Age-Related Macular Degeneration	Procedure: laser treatment

Genetics Home Reference related topics: X-linked juvenile retinoschisis

MedlinePlus related topics: Macular Degeneration

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Prevention, Randomized, Open Label, Uncontrolled, Parallel Assignment
Official Title:	Prophylactic Laser Treatment of Drusen Maculopathy in Age-Related Macular Degeneration.

Eligibility

Ages Eligible for Study:	55 Years and older
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

> 55 years of age,
Soft drusen maculopathy,
VA 0.8-1.0

Exclusion Criteria:

VA <0.8,
Pigment clumps,
PED,
CNV,
Atrophy,
Haemorrhage,
Diabetes retinopathy,
Sign cataract,
Glaucoma

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00348543

Contacts

Contact: Christina I Frennesson, MD, PhD

+46-13-222387

christina.frennesson@lio.se

Locations

Sweden
Dept of Ophthalmology, Linköping University	Recruiting
Linköping, Sweden, SE-581 85
Contact: Christina I Frennesson, MD, PhD +46-13-222387 christina.frennesson@lio.se

Sponsors and Collaborators

University Hospital, Linkoeping

Investigators

Principal Investigator:

Christina I Frennesson, MD, PhD

Linköping University

More Information

Study ID Numbers:	Dnr 97346
Study First Received:	July 3, 2006
Last Updated:	July 3, 2006
ClinicalTrials.gov Identifier:	NCT00348543
Health Authority:	Sweden: Linköping University

Study placed in the following topic categories:

Eye Diseases
Retinal Degeneration
Macular Degeneration
Retinal Diseases
Retinal degeneration

ClinicalTrials.gov processed this record on January 14, 2009